| Literature DB >> 34903986 |
Hassan Yazdanpanah1,2, Arash Mahboubi1, Samira Eslamizad1, Zakieh Karimi1, Elham Rashidi1, Jamshid Salamzadeh1.
Abstract
Veterinary drugs are extensively and legally consumed to treat and prevent disease in chattels but some are also used illegally as growth-stimulating agents. Inappropriate or intensive use of antibiotics can cause allergic reactions and, above all, antibiotic resistance. A multiclass approach for the screening of antimicrobial substances in milk was validated in consonance with Commission Decision 2002/657/EC and to the European guideline for the validation of screening methods for veterinary medicines. This biochip-based approach enables the simultaneous determination of a total of 13 sulphonamide, dapsone and trimethoprim. For monitoring of antibiotic residues, 53 UHT milk samples collected from Tehran, IR Iran were screened applying this technology. The result showed that for all antibiotic residues, the positivity threshold T was much more than the cut-off value Fm. A false positive rate of less than 5% was found for all antibiotics which are satisfactory. All detection capabilities (CCβ) were well below the Maximum Residue Level (MRL) set by the European Commission (100 µg/kg for the sum of all sulphonamides and 50 µg/kg for trimethoprim in milk). The screening results of 53 milk samples showed that 71.7% of samples were compliant and all positive samples were below the MRL set by European Commission. This study showed that the biochip-based technique is valid to identify and quantify antibiotic residues in milk at the studied validation levels. The method was rapid, easy, safe, and able to screen 13 sulphonamide, dapsone and trimethoprim from a single milk sample simultaneously with no sample preparation procedure (or just one-step centrifugation).Entities:
Keywords: Biochip; Decision 2002/657/EC; Milk; Multi-array; Screening; Sulphonamides; Validation
Year: 2021 PMID: 34903986 PMCID: PMC8653672 DOI: 10.22037/ijpr.2021.114359.14813
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Maximum Residue Limit (MRL), calibration range and spiking levels of 13 sulphonamide, DAP and TMPM
|
|
|
|
|
|---|---|---|---|
| Sulphadiazine (SDZ) | 100 | 0-40 | 20 |
| Sulphadimethoxine (SDIM) | 100 | 0-40 | 20 |
| Sulphaquinoxaline (SQX) | 100 | 0-40 | 20 |
| Sulphamethazine (SMTZ) | 100 | 0-40 | 20 |
| Sulphamethoxazole (SMXZ) | 100 | 0-25 | 12 |
| Sulphathiazole (STZ) | 100 | 0-40 | 20 |
| Sulphisoxazole (SSX) | 100 | 0-40 | 20 |
| Sulphapyridine (SPD) | 100 | 0-40 | 20 |
| Sulphamerazine (SMZ) | 100 | 0-40 | 20 |
| Sulphamonomethoxine (SMMX) | 100 | 0-240 | 50 |
| Sulphamethoxypyridazine (SMPD) | 100 | 0-40 | 20 |
| Sulphachlorpyridazine (SCPD) | 100 | 0-40 | 20 |
| Dapsone (DAP) | PS** | 0-40 | 20 |
| Sulphadoxine (SDX) | 100 | 0-40 | 20 |
| Trimethoprim (TMPM) | 50 | 0-20 | 10 |
*European Union. ** Prohibited Substance.
Figure 1The result (in RLU of the 20 negative samples and the 20 spiked samples) for sulphadimethoxine and Sulphaquinoxaline
The summary results when Fm is considered as the cut-off value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concentration | 20 | 20 | 20 | 20 | 12 | 20 | 20 | 20 | 20 | 50 | 20 | 20 | 20 | 20 | 10 |
| T value (RLU) | 4282.65 | 2961.23 | 6664.50 | 2678.30 | 2722.14 | 6235.40 | 3186.33 | 2337.10 | 5598.27 | 1706.54 | 3049.47 | 6689.48 | 4207.31 | 2421.01 | 1292.80 |
| Fmvalue (RLU) | 406.78 | 825.57 | 614.27 | 380.34 | 291.84 | 268.31 | 280.70 | 419.48 | 438.78 | 572.06 | 473.66 | 1178.84 | 826.78 | 431.28 | 260.65 |
| T > Fm | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Number of FP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| FP rate (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Number of FN | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 1 |
| FN rate (%) | 5 | 0 | 5 | 0 | 5 | 0 | 0 | 0 | 5 | 5 | 0 | 5 | 5 | 0 | 5 |
RLU: Relative light Unit; SDZ: sulphadiazine; SDIM: sulphadimethoxine; SQX: sulphaquinoxaline; SMTZ: sulphamethazine; SMXZ: sulphamethoxazole; SCPD: sulphachlorpyridazine; SSX: sulphisoxazole; SPD: sulphapyridine; SMZ: sulphamerazine; SMMX: sulphamonomethoxine; SMPD: sulphamethoxypyridazine; STZ: sulphathiazole; DAP: Dapsone; SDX: sulphadoxine; TMPM: Trimethoprim; FN: false negative; FP: false positive.
Detection capabilities CCβ
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LOD ( | 0.5 | 0.6 | 0.5 | 2.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 2 | 2 | 0.5 | 0.5 | 0.5 | 0.5 |
| Spike level used | 20 | 20 | 20 | 20 | 12 | 20 | 20 | 20 | 20 | 50 | 20 | 20 | 20 | 20 | 10 |
| CC | 20 | 20 | 20 | 20 | 12 | 20 | 20 | 20 | 20 | 50 | 20 | 20 | 20 | 20 | 10 |
The number of false-negative and false-positive results depending on the selection of the cut-off factor Fm or threshold value T as cut-off level
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T value (in RLU) (n = 20) | 4282.65 | 2961.23 | 6664.50 | 2678.30 | 2722.14 | 6235.40 | 3186.33 | 2337.10 | 5598.27 | 1706.54 | 3049.47 | 6689.48 | 4207.31 | 2421.01 | 1292.80 | |
| Cut-off = T | False positive | 0 | 3 | 1 | 1 | 2 | 0 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 |
| False negative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Fm value (in RLU) (n = 20) | 406.78 | 825.57 | 614.27 | 380.34 | 291.84 | 268.31 | 280.70 | 419.48 | 438.78 | 572.06 | 473.66 | 1178.84 | 826.78 | 431.28 | 260.65 | |
| Cut-off = Fm (n = 20) | False positive | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| False negative | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 1 |
RLU: Relative light Unit; SDZ: sulphadiazine; SDIM: sulphadimethoxine; SQX: sulphaquinoxaline; SMTZ: sulphamethazine; SMXZ: sulphamethoxazole; SCPD: sulphachlorpyridazine; SSX: sulphisoxazole; SPD: sulphapyridine; SMZ: sulphamerazine; SMMX: sulphamonomethoxine; SMPD: sulphamethoxypyridazine; STZ: sulphathiazole; DAP: Dapsone; SDX: sulphadoxine; TMPM: Trimethoprim; FN: false negative; FP: false positive.
Occurrence of sulphonamides, DAP, and TMPM in UHT treated and homogenized milk samples in RLU
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of samples | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 |
| Cut-off | 406.78 | 825.57 | 614.27 | 380.34 | 291.84 | 268.31 | 280.70 | 419.48 | 438.78 | 572.06 | 473.66 | 1178.84 | 826.78 | 431.28 | 260.65 |
| Number of positive samples | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| %Positive samples (%) | 0 | 0 | 0 | 1.88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SDZ: sulphadiazine; SDIM: sulphadimethoxine; SQX: sulphaquinoxaline; SMTZ: sulphamethazine; SMXZ: sulphamethoxazole; SCPD: sulphachlorpyridazine; SSX: sulphisoxazole; SPD: sulphapyridine; SMZ: sulphamerazine; SMMX: sulphamonomethoxine; SMPD: sulphamethoxypyridazine; STZ: sulphathiazole; DAP: Dapsone; SDX: sulphadoxine; TMPM: Trimethoprim.
Comparison of various commercial kits or the screening methods of antimicrobial drug residues in milk
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| Sulphonamides, DAP and TMPM | 15 (13) | AM | Chemiluminescent immunoassays on biochip surface | SDIM (0.6), SMTZ (2.5), SMMX (2) and others (0.5) | Approx.2.5 h | Evidence Investigator system | As per manufacturer |
| Wide range of antibiotics and Sulphonamides (SDZ and SMTZ) | 14 (2) | BR-Test AS Brilliant, DSM, The Netherlands | Bacterial growth inhibition | SDZ (25-100), SMTZ (5-200) and others (3-1000) | 2 h and 45 min | None | ( |
| Beta-lactams, tetracyclinesSulphonamides and chloramphenicol | 11 (1) | Charm II- Charm Sciences, Inc- London | Microbial or immunochemical | Sulphonamides (50-200) | Approx. 2 h 45 min | Charm II 7600 system | ( |
| Beta lactams, Sulphonamides, Tetracyclines and others. | 43 (9) | Copan Milk Test (CMT)- Copan Italia Spa- Italy | CMT combines the principle of agar diffusion with the reduction of an indicator pigment by microbial inhibition | Sulphonamides (50-150), others (2->10000) | Fixed time of 3 h | The C-Scan automatic reading system both for Microplate and Single Test versions | ( |
| Wide range of antibiotics and | 19 (2) | Delvotest ampoules or SP-NT plates | Bacterial growth inhibition | Sulphonamides (100-250) | 90 to 120 min | Delvotest | ( |
| Wide range of antibiotics and Sulphonamides | 31 (4) | Delvotest SP- DSM- The Netherlands | Bacterial growth inhibition | Sulphonamides (50-150), others (1-10000) | Reading time; 3 h | Delvoscan software available | ( |
| Wide range of antibiotics and Sulphonamides | 28 (6) | ECLIPSE 100- ZEU-INMUNOTEC- Spain | Bacterial inhibition growth | Sulphonamides (50-150), others (4-5000) | 3.15-3.30 h | None | ( |
| Sulphonamides | 5 | EIA kit (type 5101SULMp)- EuroProxima- The Netherlands | Competitive enzyme immunoassay | 1.8 | 1.5 h | Microplate reader | ( |
| Sulphonamides | - | Sulphonamides EIA 5101SULM1p- EuroProxima- The Netherlands | Competitive enzyme immunoassay ELISA | <2.5 ng/mL | 1.5 h | Micro titre plate reader | ( |
| Antibiotics and Sulphonamides | 26 (6) | Euroclone KALIDOS MP- Euroclone Spa- Italy | Bacterial growth inhibition | Sulphonamides (100-200), others (2-3000) | 3 h | None | ( |
| SDIM, SMZ Beta lactams Neomycin Streptomycin Tetracyclines Quinolones | 14 (2) | Parallux- MEDEXX Co., Ltd- Korea | Competitive EIA method | SMTZ and SDIM (10), others (2.3-75) | 4 min | Parallux processor | ( |
| Beta-lactams | 12 | Penzym®100 S- Neogen Corporation- USA | Enzymatic, colorimetric assay | 2-70 | 22 min | None | ( |
| Beta-Lactam and Tetracycline families | 18 | ROSA 3 Minute MRL Test for Beta-Lactam and Tetracycline Drugs- Charm Sciences, Inc. | Lateral Flow- Rapid receptor assay utilizing ROSA technology. 3-line reaction. | 2-100 | 3 min | ROSA reader | ( |
| Sulphonamides | 19 | HPTLC | chromatography | 10 to 20 ng/mL | Approx. 3 h | HPTLC | ( |
| Wide range of antibiotics and Sulphonamides | 16 (2) | SCREENING PLUS- ZEU-INMUNOTEC- Spain | Bacterial inhibition growth | SMXZ (50), ST (5000), others (4-5000) | 3.15-3.30 h | None | ( |
| Beta lactams, Tetracyclines, SMTZ, Gentamicin | 20 (1) | SNAP Test Kits – IDEXX- | Enzyme-linked receptor-binding assay | SMTZ (At or below 10), others (2-111) | 10 min | None or SNAPshot® reader | ( |
| Tetracycline, oxytetracycline, chlortetracycline, doxytetracycline | 4 | TECNA – SuperScreen TETRA- TecnaS.r.l.- Italy | Binding assay | 50 | 90 min (sample preparation not included) | None -Qualitative and quantitative | ( |
| Wide range of antibiotics | 32 (8) | Valio T 101 test- Valio Ltd- Finland | Bacterial growth inhibition | Sulphonamides (200-1000), others (2-5000) | 4 h 30 mn | None | ( |
SDIM: sulphadimethoxine; SMTZ: sulphamethazine; SMXZ: sulphamethoxazole; SDZ: sulphadiazine; SMMX: sulphamonomethoxine; STZ: sulphathiazole.